$IDRA Is anyone excited here after reading the following article which was published on July 24th regrading TLR7 being able to help to reduce COVID-19 infection in young population ? IDRA has IMO-8400 which is TLR7/8 and they may bring it out now along with some collaborators . Also , important point to note that the Corresponding Author of the article , Robert M. Plenge, MD, PhD, Research & Early Development, Bristol Myers Squibb, is from BMY and IDRA has very good relationship with BMY for the current IO trials. jamanetwork.com/abusenotice